Cargando…

The Universal 3D QSAR Model for Dopamine D(2) Receptor Antagonists

In order to search for novel antipsychotics acting through the D(2) receptor, it is necessary to know the structure–activity relationships for dopamine D(2) receptor antagonists. In this context, we constructed the universal three-dimensional quantitative structure–activity relationship (3D- QSAR) m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zięba, Agata, Żuk, Justyna, Bartuzi, Damian, Matosiuk, Dariusz, Poso, Antti, Kaczor, Agnieszka A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770028/
https://www.ncbi.nlm.nih.gov/pubmed/31540025
http://dx.doi.org/10.3390/ijms20184555
_version_ 1783455375418195968
author Zięba, Agata
Żuk, Justyna
Bartuzi, Damian
Matosiuk, Dariusz
Poso, Antti
Kaczor, Agnieszka A.
author_facet Zięba, Agata
Żuk, Justyna
Bartuzi, Damian
Matosiuk, Dariusz
Poso, Antti
Kaczor, Agnieszka A.
author_sort Zięba, Agata
collection PubMed
description In order to search for novel antipsychotics acting through the D(2) receptor, it is necessary to know the structure–activity relationships for dopamine D(2) receptor antagonists. In this context, we constructed the universal three-dimensional quantitative structure–activity relationship (3D- QSAR) model for competitive dopamine D(2) receptor antagonists. We took 176 compounds from chemically different groups characterized by the half maximal inhibitory concentration (IC(50))from the CHEMBL database and docked them to the X-ray structure of the human D(2) receptor in the inactive state. Selected docking poses were applied for Comparative Molecular Field Analysis (CoMFA) alignment. The obtained CoMFA model is characterized by a cross-validated coefficient Q(2) of 0.76 with an optimal component of 5, R(2) of 0.92, and an F value of 338.9. The steric and electrostatic field contributions are 67.4% and 32.6%, respectively. The statistics obtained prove that the CoMFA model is significant. Next, the IC(50) of the 16 compounds from the test set was predicted with R(2) of 0.95. Finally, a progressive scrambling test was carried out for additional validation. The CoMFA fields were mapped onto the dopamine D(2) receptor binding site, which enabled a discussion of the structure–activity relationship based on ligand–receptor interactions. In particular, it was found that one of the desired steric interactions covers the area of a putative common allosteric pocket suggested for some other G protein-coupled receptors (GPCRs), which would suggest that some of the known dopamine receptor antagonists are bitopic in their essence. The CoMFA model can be applied to predict the potential activity of novel dopamine D(2) receptor antagonists.
format Online
Article
Text
id pubmed-6770028
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67700282019-10-30 The Universal 3D QSAR Model for Dopamine D(2) Receptor Antagonists Zięba, Agata Żuk, Justyna Bartuzi, Damian Matosiuk, Dariusz Poso, Antti Kaczor, Agnieszka A. Int J Mol Sci Article In order to search for novel antipsychotics acting through the D(2) receptor, it is necessary to know the structure–activity relationships for dopamine D(2) receptor antagonists. In this context, we constructed the universal three-dimensional quantitative structure–activity relationship (3D- QSAR) model for competitive dopamine D(2) receptor antagonists. We took 176 compounds from chemically different groups characterized by the half maximal inhibitory concentration (IC(50))from the CHEMBL database and docked them to the X-ray structure of the human D(2) receptor in the inactive state. Selected docking poses were applied for Comparative Molecular Field Analysis (CoMFA) alignment. The obtained CoMFA model is characterized by a cross-validated coefficient Q(2) of 0.76 with an optimal component of 5, R(2) of 0.92, and an F value of 338.9. The steric and electrostatic field contributions are 67.4% and 32.6%, respectively. The statistics obtained prove that the CoMFA model is significant. Next, the IC(50) of the 16 compounds from the test set was predicted with R(2) of 0.95. Finally, a progressive scrambling test was carried out for additional validation. The CoMFA fields were mapped onto the dopamine D(2) receptor binding site, which enabled a discussion of the structure–activity relationship based on ligand–receptor interactions. In particular, it was found that one of the desired steric interactions covers the area of a putative common allosteric pocket suggested for some other G protein-coupled receptors (GPCRs), which would suggest that some of the known dopamine receptor antagonists are bitopic in their essence. The CoMFA model can be applied to predict the potential activity of novel dopamine D(2) receptor antagonists. MDPI 2019-09-14 /pmc/articles/PMC6770028/ /pubmed/31540025 http://dx.doi.org/10.3390/ijms20184555 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zięba, Agata
Żuk, Justyna
Bartuzi, Damian
Matosiuk, Dariusz
Poso, Antti
Kaczor, Agnieszka A.
The Universal 3D QSAR Model for Dopamine D(2) Receptor Antagonists
title The Universal 3D QSAR Model for Dopamine D(2) Receptor Antagonists
title_full The Universal 3D QSAR Model for Dopamine D(2) Receptor Antagonists
title_fullStr The Universal 3D QSAR Model for Dopamine D(2) Receptor Antagonists
title_full_unstemmed The Universal 3D QSAR Model for Dopamine D(2) Receptor Antagonists
title_short The Universal 3D QSAR Model for Dopamine D(2) Receptor Antagonists
title_sort universal 3d qsar model for dopamine d(2) receptor antagonists
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770028/
https://www.ncbi.nlm.nih.gov/pubmed/31540025
http://dx.doi.org/10.3390/ijms20184555
work_keys_str_mv AT ziebaagata theuniversal3dqsarmodelfordopamined2receptorantagonists
AT zukjustyna theuniversal3dqsarmodelfordopamined2receptorantagonists
AT bartuzidamian theuniversal3dqsarmodelfordopamined2receptorantagonists
AT matosiukdariusz theuniversal3dqsarmodelfordopamined2receptorantagonists
AT posoantti theuniversal3dqsarmodelfordopamined2receptorantagonists
AT kaczoragnieszkaa theuniversal3dqsarmodelfordopamined2receptorantagonists
AT ziebaagata universal3dqsarmodelfordopamined2receptorantagonists
AT zukjustyna universal3dqsarmodelfordopamined2receptorantagonists
AT bartuzidamian universal3dqsarmodelfordopamined2receptorantagonists
AT matosiukdariusz universal3dqsarmodelfordopamined2receptorantagonists
AT posoantti universal3dqsarmodelfordopamined2receptorantagonists
AT kaczoragnieszkaa universal3dqsarmodelfordopamined2receptorantagonists